Is the Mounjaro lawsuit a class action
BPC-157, short for Body Protection Compound 157, is a chain of fifteen amino acids with various mechanisms of action, including activating cells involved in tissue repair, including muscles, tendons, ligaments and the gastrointestinal tract, stimulating the synthesis of growth factors, and inhibiting inflammation
The approved Rybelsus dose range was set for glycaemic management, not for obesity pharmacotherapy
Common side effects are gastrointestinal (nausea, diarrhoea, vomiting), whilst serious adverse effects include pancreatitis, diabetic retinopathy complications, and acute kidney injury
Participants shed on average 10.7% of their body weight and sustained the loss to 42 weeks with only mild side-effects